59 Current news of PerkinElmer


You can refine your search further. Select from the filter options on the left to narrow down your results.

image description
PerkinElmer to Acquire In-Vitro Diagnostics Company

Endocrinology testing specialist expands PerkinElmer’s immunodiagnostics segment


PerkinElmer, Inc. and Immunodiagnostic Systems Holdings PLC (IDS) announced that they have reached an agreement on the terms of a recommended all cash offer whereby PerkinElmer will acquire IDS for approximately $155 million (£110 Million). The transaction has a total enterprise value of ...


image description
PerkinElmer Completes Acquisition of Oxford Immunotec


PerkinElmer, Inc. announced that the Company has completed its previously announced acquisition of Oxford Immunotec Global PLC (Oxford Immunotec). PerkinElmer originally announced its intent to acquire Oxford Immunotec on January 7, 2021. “Oxford Immunotec’s global role in fighting tuberculosis, ...


image description
FDA Provides Emergency Use Authorization to PerkinElmer for COVID-19 Testing


PerkinElmer, Inc. announced that the U.S. Food and Drug Administration (FDA) has provided Emergency Use Authorization (EUA) for the Company’s New Coronavirus RT-PCR test. Clinical laboratories certified under Clinical Laboratory Improvement Amendments (CLIA) can immediately begin using this kit ...


PerkinElmer Announces Leadership Succession Plan


PerkinElmer, Inc. announced that after a career of more than 20 years at the Company, including the last 12 years as chief executive officer, Robert F. Friel, has decided to retire as chairman and CEO and member of the board of directors as of the end of the Company’s fiscal year on December 29, ...


PerkinElmer appoints President & Chief Operating Officer


PerkinElmer announced that its board of directors has named Prahlad Singh president and chief operating officer, effective January 1, 2019. In his expanded position, Dr. Singh will have responsibility for both the Discovery and Analytical Solutions (DAS) and Diagnostics operating divisions of the ...


PerkinElmer appoints Chief Financial Officer


PerkinElmer, Inc. announced the appointment of James M. Mock to senior vice president and chief financial officer (CFO), effective May 1, 2018. Andy Wilson, PerkinElmer’s current senior vice president and CFO, who previously announced his retirement from PerkinElmer, will remain with the Company ...


PerkinElmer to acquire EUROIMMUN for approximately $1.3 Billion


PerkinElmer, Inc. announced that it has entered into a definitive agreement to acquireEUROIMMUN Medical Laboratory Diagnostics AG. The agreement provides that PerkinElmer will acquire up to a 100% stake in EUROIMMUN. The total purchase price of the transaction based on all outstanding shares ...


PerkinElmer completes sale of medical imaging business to Varex Imaging


PerkinElmer announced that the company has completed the sale of its Medical Imaging business to Varex Imaging Corporation. PerkinElmer announced its intent to sell its Medical Imaging business, a supplier of flat panel X-ray detectors that serve as components for industrial, medical and dental ...


PerkinElmer announces third quarter results

GAAP Revenue of $548 million versus $563 million in the comparable prior period


PerkinElmer, Inc. reported financial results for the third quarter ended October 2, 2016. The Company reported GAAP earnings per share from continuing operations of $0.52, as compared to $0.48 in the third quarter of 2015. GAAP revenue in the third quarter of 2016 was $548.1 million, as compared ...


PerkinElmer Elects Samuel Chapin to Board of Directors


PerkinElmer, Inc. announced that Samuel R. Chapin has been elected to the Company's Board of Directors. "I am pleased to welcome Samuel to our Board, as he brings extensive experience in strategic advisory, mergers and acquisitions, and deal financing for a wide range of transactions, along with ...


Page 1 From 6
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE